Medical Marijuana Faces Acceptance Barrier by Hesitant Medical Schools
A new study shows a growing interest by university pharmacy programs in teaching about medical marijuana in their curriculum, while medical schools seem to lag behind.
Sixty-two percent of U.S. pharmacy school respondents queried in a new survey said they included medical marijuana in their doctorate of pharmacy curriculum.
That’s according to a nine-page study co-authored by faculty from the University of Pittsburgh School of Pharmacy, which appeared in the January 2019 issue of the journal Currents in Pharmacy Teaching and Learning. The results point to the growing role of marijuana as a therapeutic treatment. Read the full article.
Stories you may be interested in
CEO Spotlight: James West
As a former academic coordinator for the City University of New York Research Foundation and Medgar Evers College, CEO and co-founder of Arfinn Med, James West, has extensive experience in adult education and professional training programming. James put this extensive education to good use when he noticed that there was a direct need for a…
Read More 
Doctors and patients are flying blind as medical marijuana use rises, research lags
Marijuana’s role in the health care universe has grown exponentially over the past few years. Currently, 33 U.S. states have legalized the use of medical marijuana, and more and more states are considering making it legal for recreational purposes as well. As cannabis becomes more accessible, many people are turning to tetrahydrocannabinol (THC) and cannabidiol (CBD) products to…
Read More 
Colorado looks to medical marijuana to ease opioid crisis
As the nation grapples with an opioid crisis that kills more than 130 people every day, Colorado thinks a solution may lie in a joint, a vape pen or a topical. On Friday, it becomes the third state in the nation after New York and Illinois to allow doctors to recommend medical marijuana for any condition…
Read More 
July Updates
In our quest to save medical marijuana clinics valuable time, Arfinn Med has continued to release new functionality that improves EMR workflows. This has led to the development of our new telehealth platform, new automated patient intake emails, and generating all state required documentation. Continuing on our quest, we are proud to release our new…
Read More 
After 50 Years, U.S. Opens The Door To More Cannabis Crops For Scientists
After more than 50 years, the federal government is lifting a roadblock to cannabis research that scientists and advocates say has hindered rigorous studies of the plant and possible drug development. Since 1968, U.S. researchers have been allowed to use cannabis from only one domestic source: a facility based at the University of Mississippi, through a…
Read More 
Substance in cannabis ‘could boost pancreatic cancer treatments’
A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More